Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-25T16:46:03.107Z Has data issue: false hasContentIssue false
  • English
  • Français

Rationale behind psychiatrists' choice of drug

Published online by Cambridge University Press:  02 January 2018

John Dickson-Mulinga
John Dickson-Mulinga*
Affiliation:
Withington Hospital Nell Lane, West Didsbury, Manchester M20 8LR
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims and method

The study investigated the reasons that influence medical staffs' choice of a specific drug over another given the same clinical situation, by use of a questionnaire-based survey. The study population was 88 clinicians of various ranks, at psychiatry units in National Health Service university and district general hospitals In Greater Manchester. Responses in the factors: personal experience, scientific evidence, influence from colleagues, economic consideration, influence by drug representatives, ward or unit policy and other in choice of prescription, were the main outcome measures.

Results

Of the 546 responses generated by the 88 clinicians, 263 (48.2%) were for personal experience as the most important influence on choice of prescription. Scientific evidence was the second most important factor with 117 (21.4%) responses. Economic consideration and influence by drug representatives were least important. This trend held for all ranks except for registrars, where scientific evidence was as important as personal experience.

Clinical implications

As prescribers, clinicians trust mostly in their own personal experience. This may not be unique to psychiatrists. An understanding of how clinicians gain ‘personal experience’ could be important in improving rational prescribing.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 22 , Issue 11 , November 1998 , pp. 677 - 680
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1998 The Royal College of Psychiatrists

References

Bateman, D. N., Eccles, M., Campbell, M., et al (1996) Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. British Journal of General Practice, 46, 20–25.Google Scholar
Hogerzeil, H. V. (1995) Promoting rational prescribing: an international perspective. British Journal of Clinical Pharmacology, 39, 1–6.Google Scholar
Lexchin, J. (1993) Interactions between physicians and the pharmaceutical industry: What does the literature say? Canadian Medical Association Journal 149, 1401–1406.Google Scholar
MacLeod, S. M. (1996) Improving physician prescribing practices: bridge over troubled waters. Canadian Medical Association Journal 154, 675–677.Google ScholarPubMed
Macpherson, R. & Robson, E. (1994) How do clinicians choose antidepressants? Psychiatric Bulletin, 18, 597–599.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.